|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/127 | (2025.01) |
| A61K 39/0011 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61K 9/1272 | (2013.01) | ||
| A61K 48/00 | (2006.01) | ||
| A61K 48/0025 | (2013.01) | ||
| A61K2039/53 | (2013.01) | ||
| A61K2039/55555 | (2013.01) |
| (11) | Number of the document | 3777840 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20189077.9 |
| Date of filing the European patent application | 2013-03-25 | |
| (97) | Date of publication of the European application | 2021-02-17 |
| (45) | Date of publication and mention of the grant of the patent | 2025-04-23 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| PCT/EP2012/001319 | 2012-03-26 | WO |
| (72) |
SAHIN, Ugur , DE
HAAS, Heinrich , DE
KREITER, Sebastian , DE
DIKEN, Mustafa , DE
FRITZ, Daniel , DE
MENG, Martin , DE
KRANZ, Lena Mareen , DE
WALZER, Kerstin , DE
|
| (73) |
BioNTech SE ,
An der Goldgrube 12, 55131 Mainz,
DE
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH , Freiligrathstrasse 12, 55131 Mainz, DE |
| (54) | RNA FORMULATION FOR IMMUNOTHERAPY |
| RNA FORMULATION FOR IMMUNOTHERAPY |